Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations from the last five years
Projects
- 1 Active
-
EPIC-1: A phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic Pancreatic Cancer
Flak, R. V., Ladekarl, M., Poulsen, L. Ø., Thorlacius-Ussing, O., Stender, M. T., Detlefsen, S., Agger, R., Kofod-Olsen, E. & Wanders, A.
01/01/2021 → 31/12/2025
Project: Research
Research output
-
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation
Kirkegård, J., Ladekarl, M., Johannsen, I. R. & Mortensen, F., 3 Jan 2024, In: British Journal of Surgery. 111, 1, znad398.Research output: Contribution to journal › Journal article › Research › peer-review
-
Germline variants in patients with end-stage cancer
Lundsgaard, M., Mapendano, C., Sønderkær, M., Ernst, A., Pedersen, I. S., Nohr, A. K., Ladekarl, M. & Sunde, L., 8 Jan 2024, In: European Journal of Human Genetics. 32, Suppl. 1, p. 557 1 p., P13.039.C.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation
Kirkegård, J., Ladekarl, M., Lund, A. & Mortensen, F., Feb 2024, In: Annals of Surgical Oncology. 31, 2, p. 1310-1318 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial
Baeksgaard Jensen, L., Yilmaz, M., Nordsmark, M., Möller, S., Elle, I. C., Ladekarl, M., Qvortrup, C. & Pfeiffer, P., Apr 2024, In: EClinicalMedicine. 70, 10 p., 102521.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
ABCG transporter and SRPK1 kinase inhibition of chemotherapy resistance: A phase Ib clinical trial of safety and maximum tolerated dose for SCO-101 in combination with gemcitabine and nab-paclitaxel in inoperable pancreatic cancer
Ladekarl, M., Shim, S., Ettrich, T. J., Kestler, A., Pfeiffer, P., Tarpgaard, L. S., Reinacher-Schick, A., Kraeft, A-L., Stenvang, J., Zurlo, A. & Roest, N. L., Oct 2023, In: Annals of Oncology. 34, Suppl. 2, p. S907 1 p., 1641P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Datasets
-
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mouritzen, M. T. (Creator), Junker, K. F. (Creator), Carus, A. (Creator), Ladekarl, M. (Creator), Meldgaard, P. (Creator), Nielsen, A. W. M. (Creator), Livbjerg, A. (Creator), Larsen, J. W. (Creator), Skuladottir, H. (Creator), Kristiansen, C. (Creator), Wedervang, K. (Creator), Schytte, T. (Creator), Hansen, K. H. (Creator), Østby, A. (Creator), Frank, M. S. (Creator), Lauritsen, J. (Creator), Sørensen, J. B. (Creator), Langer, S. W. (Creator), Persson, G. F. (Creator), Andersen, J. L. (Creator), Homann, P. H. (Creator), Kristensen, E. B. (Creator), Drivsholm, L. B. (Creator), Bøgsted, M. (Creator), Christensen, H. S. (Creator), Pøhl, M. (Creator) & Bjørnhart, B. (Creator), Taylor & Francis, 2022
DOI: 10.6084/m9.figshare.18134004.v1, https://tandf.figshare.com/articles/journal_contribution/Clinical_features_affecting_efficacy_of_immune_checkpoint_inhibitors_in_pretreated_patients_with_advanced_NSCLC_a_Danish_nationwide_real-world_study/18134004/1
Dataset
-
Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer
Ladekarl, M. (Creator), Rasmussen, L. S. (Creator), Kirkegård, J. (Creator), Chen, I. (Creator), Pfeiffer, P. (Creator), Weber, B. (Creator), Skuladottir, H. (Creator), Østerlind, K. (Creator), Larsen, J. S. (Creator), Mortensen, F. V. (Creator), Engberg, H. (Creator), Møller, H. (Creator) & Fristrup, C. W. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17150821.v1, https://tandf.figshare.com/articles/journal_contribution/Disparity_in_use_of_modern_combination_chemotherapy_associated_with_facility_type_influences_survival_of_2655_patients_with_advanced_pancreatic_cancer/17150821/1
Dataset
-
The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study
Skau Rasmussen, L. (Contributor), Vittrup, B. (Creator), Ladekarl, M. (Creator), Pfeiffer, P. (Creator), Karen Yilmaz, M. (Contributor), Østergaard Poulsen, L. (Contributor), Østerlind, K. (Creator), Palnæs Hansen, C. (Contributor), Bau Mortensen, M. (Contributor), Viborg Mortensen, F. (Contributor), Sall, M. (Creator), Detlefsen, S. (Creator), Bøgsted, M. (Creator) & Wilki Fristrup, C. (Contributor), Taylor & Francis, 2019
DOI: 10.6084/m9.figshare.7886510.v1, https://doi.org/10.6084%2Fm9.figshare.7886510.v1
Dataset
Activities
- 3 Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Danish Regions (External organisation)
Morten Ladekarl (Chairperson)
1 Jan 2020 → …Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Dansk Comprehensive Cancer Center (External organisation)
Morten Ladekarl (Chairperson)
1 Jan 2020Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Danish Health Authority (External organisation)
Morten Ladekarl (Chairperson)
1 Jan 2005 → …Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
Press/Media
-
Ny metode til screening for kræft i bugspytkirtlen?
05/02/2024
1 item of Media coverage
Press/Media: Press / Media
-
Ny metode til screening for kræft i bugspytkirtlen?
25/01/2024
1 item of Media coverage
Press/Media: Press / Media
-
Sundhedsstyrelsen har sammensat nyt rådgivende panel
Morten Ladekarl & Tarec Christoffer El-Galaly
02/11/2023
1 item of Media coverage
Press/Media: Press / Media
-
Kræftdødeligheden falder markant i Danmark
13/06/2023 → 14/06/2023
2 items of Media coverage
Press/Media: Press / Media
-
Potentielt praksisændrende: Nyt antistof øger overlevelsen mod kræft i mavesæk og mavemund
23/01/2023 → 24/01/2023
2 items of Media coverage
Press/Media: Press / Media